Institutional Ownership Bolt Biotherapeutics, Inc. (BOLT)
This table provides information about the institutional ownership of Bolt Biotherapeutics, Inc. (BOLT). We have compiled data on the 36 institutions that hold shares in the stock, with a total of 18.3 Million shares, which have been reported (via 13F filing form) to have a value of $6.77 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Mariner, LLC
Overland Park, KS |
Feb 13, 2025 Q4 2024 |
35,000
shares
|
$12,250
0.0% of portfolio
|
Q4 2024
Reduced 13.65%
|
|
|
Virtu Financial LLC
New York, NY |
Feb 11, 2025 Q4 2024 |
29,552
shares
|
$10,343
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
17,355
shares
|
$6,074
0.0% of portfolio
|
Q3 2024
Added 15.7%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
11,616
shares
|
$4,065
0.0% of portfolio
|
Q4 2024
Reduced 50.46%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
5,625
shares
|
$1,968
0.0% of portfolio
|
Q4 2024
Reduced 6.25%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Feb 13, 2025 Q4 2024 |
4,008
shares
|
$1,402
0.0% of portfolio
|
Q4 2024
Added 2078.26%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
911
shares
|
$318
0.0% of portfolio
|
Q4 2024
Reduced 0.33%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Feb 05, 2025 Q4 2024 |
200
shares
|
$70
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
139
shares
|
$48
0.0% of portfolio
|
Q2 2023
Reduced 5.44%
|
|
|
Salem Investment Counselors Inc
Winston Salem, NC |
Apr 16, 2025 Q1 2025 |
40
shares
|
$14
0.0% of portfolio
|
Q1 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|